Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Melda Onal

Federal Grant PI

Assistant Professor

Also affiliated: University of Wisconsin–Madison (2014–2019); University of Arkansas Medical Center (2011); Central Arkansas Veterans Healthcare System (2011–2016)

Physiology & Cell Biology, College of Medicine

19 h-index 37 pubs 3,267 cited

  • Animals
  • Mice
  • Osteoblasts
  • Female
  • Autophagy
  • RANK Ligand
  • Osteoclasts
  • Bone Density
  • Male
  • Gene Expression Regulation
  • Mice, Knockout
  • Enhancer Elements, Genetic
  • Bone and Bones
  • Mice, Inbred C57BL
  • Mice, Transgenic

Biography and Research Information

OverviewAI-generated summary

Melda Onal's research focuses on the cellular and molecular mechanisms of skeletal diseases, with a particular emphasis on bone metabolism and the role of autophagy. Her work investigates how cells within the bone matrix, specifically osteocytes, osteoblasts, and lining cells, contribute to osteoclast formation, a critical process in bone remodeling. Onal has explored the function of receptor activator of nuclear factor kappa-B ligand (RANKL) in this process, including its expression by B lymphocytes and its contribution to bone loss, such as that induced by ovariectomy.

Her research also examines the impact of autophagy, a cellular self-degradation process, on skeletal aging and bone mass. Studies have shown that suppression of autophagy in osteocytes can mimic skeletal aging, and that mice lacking autophagy in their osteoblast lineage exhibit low bone mass and altered osteocyte networks. Onal has received federal funding from the NIH/National Institute on Aging for her work on the role of autophagy in skeletal diseases. Additionally, she has been funded by the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases for research on CRISPR inhibition as an alternative to Cre-loxP systems.

Her scholarship metrics include an h-index of 19, with 39 total publications and over 3,200 citations. Onal collaborates with researchers at the University of Arkansas for Medical Sciences, including Jinhu Xiong, Charles A. O’Brien, Maria Almeida, and A. Gordon James, with whom she has co-authored multiple publications.

Metrics

  • h-index: 19
  • Publications: 37
  • Citations: 3,267

Positions

  • Assistant Professor publications 2011–2026
    University of Arkansas for Medical Sciences Physiology & Cell Biology, College of Medicine Institutional directory
  • University of Arkansas for Medical Sciences publications 2011–2026
    ORCID

Selected Publications

  • Autophagy in Osx1-Cre-targeted cells is essential for development, growth, and maintenance of bone (2026)
    Bone Reports DOI OpenAlex
  • TFEB-mediated autophagy stimulation as an anabolic strategy for bone: insights from TFEB activation in the osteoblast lineage (2025)
    Autophagy Reports 1 citation DOI OpenAlex
  • The Aging Landscape by scRNAseq of Mesenchymal Lineage Cells in Mouse Bone (2025)
    Aging Cell 6 citations DOI OpenAlex
  • Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength (2025)
    JCI Insight 13 citations DOI OpenAlex
  • Mitochondrial oxidative stress or decreased autophagy in osteoblast lineage cells is not sufficient to mimic the deleterious effects of aging on bone mechanoresponsiveness (2025)
    Aging 4 citations DOI OpenAlex
  • A new Col1a1 conditional knock-in mouse model to study osteogenesis imperfecta (2024)
    Journal of Bone and Mineral Research 3 citations DOI OpenAlex
  • CRISPR activation of Tfeb , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength (2024)
    bioRxiv (Cold Spring Harbor Laboratory) 1 citation DOI OpenAlex
  • Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)
    Journal of Biological Chemistry 33 citations DOI OpenAlex
  • Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice (2024)
    FASEB BioAdvances 3 citations DOI OpenAlex
  • A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone (2023)
    bioRxiv (Cold Spring Harbor Laboratory) 1 citation DOI OpenAlex
  • CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system (2023)
    iScience 7 citations DOI OpenAlex
  • Novel methods for the generation of genetically engineered animal models (2022)
    Bone 8 citations DOI OpenAlex
  • Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass (2022)
    Scientific Reports 12 citations DOI OpenAlex
  • Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo (2021)
    PLoS ONE 8 citations DOI OpenAlex
  • Effective CRISPR interference of an endogenous gene via a single transgene in mice (2019)
    Scientific Reports 31 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 2 $650,031 total

NIH Contact PI Jun 2026 - Mar 2031

Role of Autophagy in skeletal diseases

National Institute on Aging $487,847 R01
NIH Contact PI Jan 2020 - Dec 2021

CRISPR inhibition as an alternate for Cre-loxP

National Institute of Arthritis and Musculoskeletal and Skin Diseases $162,184 R21

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
  • DEAP Awards - P. Drew - UAMS VCRI - FY26 Role of Oligodendrocyte-Lineage Cells in FASD UAMS Division of Research and Innovation Principal Investigator

Collaboration Network

67 Collaborators 11 Institutions 4 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics